首頁 › 神經膠質瘤 › 哥倫比亞特區 › Washington
Washington, DC 的 神經膠質瘤 臨床試驗
19 項針對 神經膠質瘤 的研究正在 Washington（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
招募中1/2 期
- Children's National Medical Center, Washington D.C.
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
招募中2 期
- Children's National Medical Center, Washington D.C.
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
招募中1 期
- Children's National Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
招募中觀察性研究
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Children's National Medical Center, Washington D.C.
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Children's National Medical Center, Washington D.C.
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
招募中1 期
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距離 7 英里
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
招募中1/2 期
- Children's National Hospital, Washington D.C.
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期第 1 期歡迎健康志工
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
招募中1 期
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Sibley Memorial Hospital, Washington D.C.
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
招募中早期第 1 期
- Children's National Medical Center, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
招募中1 期
- National Institutes of Health, Bethesda · 距離 7 英里
其他城市的 神經膠質瘤 試驗
- New York City, NY25 項研究
- Houston, TX23 項研究
- Boston, MA20 項研究
- Philadelphia, PA16 項研究
- Columbus, OH15 項研究
- Miami, FL15 項研究
- San Francisco, CA14 項研究
- Chicago, IL13 項研究
- Durham, NC12 項研究
- Seattle, WA11 項研究
- St. Louis, MO10 項研究
- Aurora, CO10 項研究
Washington 的其他研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌55 項研究
- 乳癌46 項研究
- 轉移性癌症43 項研究
- 肺癌41 項研究
- 前列腺癌38 項研究
- 肥胖症33 項研究
- 大腸直腸癌29 項研究
- 心血管疾病28 項研究
- 膀胱癌26 項研究
- 急性髓系白血病24 項研究
- 卵巢癌23 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。